p16, Cyclin D1, and HIF-1αPredict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy

Asal S. Rahimi; David D. Wilson; Drew K. Saylor; Edward B. Stelow; Christopher Y. Thomas; James F. Reibel; Paul A. Levine; David C. Shonka; Mark J. Jameson; Paul W. Read

doi:10.1155/2012/685951

p16, Cyclin D1, and HIF-1αPredict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy

By Asal S. Rahimi, David D. Wilson, Drew K. Saylor, Edward B. Stelow, Christopher Y. Thomas, James F. Reibel, Paul A. Levine, David C. Shonka, Mark J. Jameson and Paul W. Read

Publisher: Hindawi Limited

Year: 2012

DOI identifier: 10.1155/2012/685951

OAI identifier:

Provided by: MUCC (Crossref)

Download PDF:
_{Sorry, we are unable to provide the full text but you may find it at the
following location(s):}

http://downloads.hindawi.com/j... (external link)

p16, Cyclin D1, and HIF-1αPredict Outcomes of Patients with Oropharyngeal Squamous Cell Carcinoma Treated with Definitive Intensity-Modulated Radiation Therapy

Suggested articles